Expand what's possible in neurovascular theraoy

About Us

At Rapid Medical, we’re dedicated to redefining what’s possible in neurovascular therapy. We believe every stroke is unique—and that treatment should be too. Using advanced active technologies and proprietary manufacturing techniques, we deliver tools that adapt to individual patient anatomy, enabling physicians to act with precision, flexibility, and control.

With over 40,000 patients treated, 100+ issued patents, and more than 75 peer-reviewed clinical publications, our commitment to innovation and patient safety drives everything we do. From engineering breakthroughs in ischemic and hemorrhagic stroke care to evidence-backed therapies, our goal is simple: to give clinicians the solutions they need to restore health and hope, one patient at a time.

Look at the Leaders of Rapid Medical

Ronen Eckhouse

Co-Founder & CEO

Michal Shriki

Chief Financial Officer

Dr. Walid Haddad

Chief Clinical Officer

Featured Therapies and Innovations

TIGERTRIEVER™

87% of all strokes are ischemic and caused by a blood clot that disrupts blood flow in the brain. Active thrombectomy with TIGERTRIEVER™ enables fast revascularization and real-time adjustability for better patient outcomes.

COMANECI™

Hemorrhagic stroke is caused by a blood vessel that ruptures in the brain. COMANECI™ is the only non-occlusive, active assist device to treat wide-neck aneurysms without occluding blood flow or permanent implants.

DRIVEWIRE™

DRIVEWIRE™ redefines access. Active technology enables distal steering to select vessels and navigate a large range of catheters with ease.

Company Spotlight Video

News and Stories

Rapid Medical™ Surpasses 1,000 Cases With DRIVEWIRE™ 24 in North America and Expands Into Europe With MDR Approval

Rapid Medical announces enrolment in “first-ever” study on cognitive benefits of thrombectomy device

30 January 2025 — Rapid Medical has announced enrolment of the first patient in its COGNITIVE study—which, according to the company, is the first study to examine a link between mechanical thrombectomy and cognitive improvement. Tigertriever—described by Rapid as “the only active stent retriever”—may uniquely preserve cognitive function with a tailored approach to removing thrombus while limiting impact to the natural vessel.

Rapid completes interim safety analysis of DISTALS study evaluating Tigertriever 13 device

Looking to stand out from the crowd during your job search? Click below to gain access to our top tips & tools for candidates during the hiring process!

Floodgatemedical-logo

Recruiting Done Differently. 

Improving lives by uniting great people with great companies.

Sign up for our Monthly Newsletter

We’re committed to sharing up-to-date industry insights, our newest career opportunities, and valuable tools to support you throughout your next job search. Let’s stay connected!